slides · global inventory
Source Note
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 110,355
Current window 47,641-47,670
Pages 3,679
Rows per page 30
Component
47,641-47,670 of 110,355
135
The slide uses a Q&A format to highlight alleged unethical business practices.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
136
The slide uses highlighted quotes from transplant surgeons to build a case for potential regulatory or ethical issues regarding TransMedics' business practices.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
137
The slide uses a Q&A format to highlight a specific allegation of unethical business practices.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
138
The slide presents a Q&A format with a surgeon, highlighting allegations of unethical business practices and operational friction.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
139
The slide uses a Q&A format to present testimonial evidence of alleged misconduct.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
140
The slide uses a Q&A format to provide direct evidence of unethical behavior in the organ transplant system.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
141
The slide uses a Q&A format to highlight alleged procedural violations. The yellow highlighting emphasizes the specific claims of bypassing the OPO.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
142
Includes a Q&A transcript excerpt highlighting potential ethical/regulatory concerns regarding organ allocation and communication methods.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
143
The slide uses a 'smoking gun' narrative to frame the testimonial as evidence of unethical business practices.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
144
Includes a Q&A transcript excerpt as evidence for the allegations.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
145
The slide uses a Q&A format to present testimony from an industry veteran, highlighting allegations of unethical sales practices.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
146
The slide uses a Q&A format to highlight potential regulatory violations by TransMedics.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
147
The slide uses a combination of summary text and a direct quote from a high-volume user to substantiate the claim of unethical organ allocation practices.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
148
The slide uses a Q&A format to highlight alleged unethical business practices.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
149
The slide uses screenshots of the UNOS/UNet portal to establish the system's official status and legal warnings.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
150
The slide uses a Q&A transcript format to highlight potential ethical concerns regarding vendor access to sensitive medical data.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
151
The slide presents two Q&A excerpts from a transplant surgeon to support the claim that TransMedics is hijacking the organ allocation process.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
152
The slide uses direct quotes from industry experts to build a case against TransMedics' business practices.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
153
The slide uses a Q&A format to highlight potential misuse of system access.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
157
The slide uses a testimonial to undermine the corporate narrative of 'Game Changer' technology, suggesting it is instead a tool for labor convenience.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
158
The slide uses a testimonial/interview format to challenge the necessity of the OCS device for local transplants.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
159
The slide uses Q&A transcripts to undermine a business model premise.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
160
The slide uses direct quotes from transplant directors to challenge the value proposition of TransMedics' NOP service.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
161
The slide uses a Q&A format to substantiate the claim of reckless off-label usage.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
162
The slide uses a Q&A format to present expert testimony regarding potential misuse of medical devices.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
163
The slide uses direct quotes to expose a misalignment between the stated value proposition (reduced hospitalization) and the actual usage (scheduling convenience).TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
164
The slide uses a primary headline followed by a detailed supporting quote, highlighting the ethical and financial concerns regarding off-label use of perfusion technology.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
165
The slide uses a Q&A format to present a negative testimonial/critique of the company's sales tactics.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
166
The slide uses direct quotes from UCSF hospital administrators to frame the argument that TransMedics usage is being curtailed due to cost and lack of clinical indication.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
167
Uses direct quotes from surgeons at Utah and UCSD to support the thesis of off-label, convenience-driven usage.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit